These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1881464)

  • 1. Action of the racemate and the isomers of the platelet-activating factor antagonist bepafant (WEB 2170) after oral administration to guinea-pigs and rats.
    Heuer HO; Keller B; Urich K
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):546-50. PubMed ID: 1881464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WEB 2347: pharmacology of a new very potent and long acting hetrazepinoic PAF-antagonist and its action in repeatedly sensitized guinea-pigs.
    Heuer HO
    J Lipid Mediat; 1991; 4(1):39-44. PubMed ID: 1893086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
    Heuer HO
    Eur J Pharmacol; 1991 Jun; 199(2):157-63. PubMed ID: 1954975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
    Terasawa M; Aratani H; Setoguchi M; Tahara T
    Prostaglandins; 1990 Dec; 40(6):553-69. PubMed ID: 2093935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist.
    Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K
    Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
    Casals-Stenzel J
    Immunopharmacology; 1987 Apr; 13(2):117-24. PubMed ID: 3597059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aeroallergen-induced bronchial eosinophilia by azelastine in guinea pigs.
    Chand N; Nolan K; Diamantis W; Sofia RD
    Int Arch Allergy Immunol; 1992; 97(3):229-32. PubMed ID: 1587636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octylonium bromide, an antagonist of platelet-activating factor.
    Subissi A; Del Monte M; Evangelista S; Santicioli P; Criscuoli M
    Arch Int Pharmacodyn Ther; 1989; 302():255-67. PubMed ID: 2636821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of oral E6123, a novel PAF antagonist, on biological changes induced by PAF inhalation in guinea pigs.
    Sakuma Y; Tsunoda H; Shirato M; Katayama S; Yamatsu I; Katayama K
    Prostaglandins; 1991 Nov; 42(5):463-72. PubMed ID: 1763202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
    Casals-Stenzel J
    Eur J Pharmacol; 1987 Mar; 135(2):117-22. PubMed ID: 3582490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triazolodiazepine platelet activating factor receptor antagonist (WEB 2086) reduces pulmonary dysfunction during endotoxin shock in swine.
    Siebeck M; Weipert J; Keser C; Kohl J; Spannagl M; Machleidt W; Schweiberer L
    J Trauma; 1991 Jul; 31(7):942-9; discussion 949-50. PubMed ID: 1906548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
    Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
    Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.